Wang Dong, Zhang Kai, Han ShaoLong, Yu LingZhi
Department of Pain Management, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong, China; Department of Anesthesia, Zhangqiu District Chinese Medical Hospital, Jinan, Shandong, China.
Department of Anesthesia, Zhangqiu District Chinese Medical Hospital, Jinan, Shandong, China.
Biomed Res Int. 2017;2017:5670219. doi: 10.1155/2017/5670219. Epub 2017 Mar 5.
. PainVision device was a developed application for the evaluation of pain intensity. The objective was to assess the efficacy and safety of pulsed radiofrequency (PRF) combined with pharmacological therapy in the treatment of postherpetic neuralgia (PHN). We also discussed the correlation of the measurements. . Forty patients with PHN were randomized for treatment with PRF combined with pharmacological therapy (PRF group, = 20) or pharmacological therapy (control group, = 20) at postoperative 48 hours. The efficacy measure was pain degree (PD) that was assessed by PainVision and visual analog scale (VAS), short form Mcgill pain questionnaire (SF-Mcgill), and numeric rate scale sleep interference score (NRSSIS). Correlations between PD, VAS, SF-Mcgill, and NRSSIS were determined. . The PD for persistent pain (PP) and breakthrough pain (BTP) at postoperative 48 hours assessed by PainVision were significantly lower in PRF group than in control group (PD-PP, < 0.01; PD-BTP, < 0.01). PD and VAS were highly correlated for both persistent pain ( = 0.453, = 0.008) and breakthrough pain ( = 0.64, = 0.001). . PRF was well tolerated and superior to isolated pharmacological therapy in the treatment of PHN. PainVision device showed great value in the evaluation of pain intensity and PD had an excellent correlation with VAS and SF-Mcgill.
疼痛视觉设备是一种用于评估疼痛强度的开发应用程序。目的是评估脉冲射频（PRF）联合药物治疗带状疱疹后神经痛（PHN）的疗效和安全性。我们还讨论了测量结果的相关性。40例PHN患者在术后48小时被随机分为接受PRF联合药物治疗组（PRF组，n = 20）或药物治疗组（对照组，n = 20）。疗效评估指标为疼痛程度（PD），通过疼痛视觉设备、视觉模拟量表（VAS）、简短麦吉尔疼痛问卷（SF - 麦吉尔）和数字评分量表睡眠干扰评分（NRSSIS）进行评估。确定了PD、VAS、SF - 麦吉尔和NRSSIS之间的相关性。通过疼痛视觉设备评估，PRF组术后48小时持续性疼痛（PP）和爆发性疼痛（BTP）的PD显著低于对照组（PD - PP，P < 0.01；PD - BTP，P < 0.01）。持续性疼痛（r = 0.453，P = 0.008）和爆发性疼痛（r = 0.64，P = 0.001）的PD与VAS均高度相关。PRF耐受性良好，在治疗PHN方面优于单纯药物治疗。疼痛视觉设备在评估疼痛强度方面显示出巨大价值，且PD与VAS和SF - 麦吉尔具有良好的相关性。
